http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f58e7740751b33aeb9233d0a7f8985dd
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Vergote |
| name | Ignace Vergote |
| given-name | Ignace |
| organization-name | From the Department of Obstetrics and Gynecology, University Hospitals Katholieke Universiteit Leuven; Department of Electrical Engineering, ESAT-SISTA, Katholieke Universiteit Leuven, Belgium; Department of Obstetrics and Gynaecology, King's College Hospital; Department of Obstetrics and Gynaecology, St George's Hospital Medical School, University of London, London, United Kingdom; Department of Obstetrics and Gynaecology, Malmö University Hospital, Malmö, Sweden; Istituto di Clinica Ostetrica e... From the Departments of Obstetrics and Gynecology, Radiology, Rheumatology, Electrical Engineering, Orthopedic Surgery, Medical Oncology, and the Multidisciplinary Breast Center, Leuven Kanker Instituut, Katholieke Universiteit Leuven, University Hospitals KU, Leuven, Belgium Leuven Cancer Institute, Leuven, Belgium Department of Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of Gynecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium University Hospital Leuven, Leuven Cancer Institute, Leuven, and Belgian and Luxembourg Gynaecological Oncology Group (BGOG), Belgium. Department of Gynecology and Obstetrics, Division of Gynecological Oncology Belgium and Luxemburg Gynaecological Oncology Group, University Hospitals Leuven, Leuven, Belgium Katholieke Universiteit Leuven, Leuven, Belgium; Universitaire Ziekenhuizen Leuven, Leuven, Belgium Belgian Gynaecological Oncology Group and University Hospital Leuven, Leuven, Belgium Authors' Affiliations: Departments of 1Health Sciences Research, Division of Epidemiology, 2Medical Oncology, 3Health Sciences Research, Division of Biomedical Statistics and Informatics, 4Immunology, and 5Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota; 6Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida; 7Channing Division of Network Medicine, 8Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School; 9Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 10Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut; 11Department of Clinical Science, University of Bergen; Departments of 12Gynecology and Obstetrics, and 13Pathology, Haukeland University Hospital, Bergen, Norway; Departments for 14Health Evidence, 15Urology, and 16Gynaecology, Radboud University Medical Centre, Nijmegen; 17 Division of Gynaecological Oncology, Department of Obstetrics & Gynaecology, Leuven Cancer Institute, University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium ENGOT/BGOG and University Hospital Leuven, Gynaecological Oncology, Leuven Cancer Institute, Herestraat 49, 3000 Leuven, Belgium, European Union. Electronic address: Ignace.vergote@uz.kuleuven.ac.be. Alexi A. Wright, Dana-Farber Cancer Institute, Harvard Medical School; Don S. Dizon, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Deborah K. Armstrong, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Michael A. Bookman, US Oncology Research and Arizona Oncology, Tucson, AZ; William A. Cliby, Mayo Clinic, Rochester, MN; Robert L. Coleman and Larissa A. Meyer, The University of... From the University Medical Center Groningen, University of Groningen, Groningen; Radboud University Nijmegen Medical Center, Nijmegen; Erasmus Medical Center, Rotterdam; VU University Medical Center; Academic Medical Center, Amsterdam; Leiden University Medical Center, Leiden; University Medical Center Utrecht, Utrecht; Maastricht University Medical Center, Maastricht; Catharina Hospital, Eindhoven, the Netherlands; University Hospitals Leuven, Leuven, Belgium; European Cancer Institute, Milan, Italy;... Department of Gynecologic Oncology Leuven Cancer Institute, University Hospitals Leuven, KU Leuven Leuven Belgium Multidisciplinary Breast Center, Department of Gynecological Oncology, and ESAT-SCD, Universitaire Ziekenhuizen Gasthuisberg, Katholieke Universiteit, Leuven, Belgium Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven Cancer Institute, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium University Hospitals, K.U. Leuven Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Herestraat 49, B-3000 Leuven, Belgium. ignace.vergote@uzleuven.be Department of Gynecologic Oncology, University Hospital Leuven, Leuven, Belgium European Network of Gynaecological Trial, Geneva, Switzerland. engot@esgo.org I. Vergote, MD, PhD, Department of Gynecological Oncology, University Hospitals Leuven, and Leuven Cancer Institute, Leuven, Belgium. Department of Gynecological Oncology University Hospitals Leuven, Leuven Cancer Institute Leuven Belgium Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Belgium. Authors' Affiliations: 1Department of Obstetrics and Gynecology, University Hospitals K.U. Leuven; 2Department of Electrical Engineering, 3IBBT-K.U. Leuven Future Health Department, Katholieke Universiteit Leuven, Leuven, Belgium; 4Department of Obstetrics and Gynecology, Skåne University Hospital Malmö, Lund University, Sweden; 5Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium; 6Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China; 7Gynecology Diagnostic and Outpatient Treatment Unit, University College Hospital, 8Department of Obstetrics and Gynecology, Imperial College, Hammersmith Campus, London, United Kingdom; 9Clinica Ostetrica e Ginecologica, Ospedale San Gerardo, Università di Milano-Bicocca, Monza; 10Istituto di Clinica Ostetrica e Ginecologica, Università Cattolica del Sacro Cuore, Rome, Italy; 111st Department of Gynecology, Medical University of Lublin, Lublin, Poland; 12Oncogynecological Center, Department of Obstetrics and Gynecol Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium Tumorbank Ovarian Cancer Network Berlin Germany; Department of Gynecology and Obstetrics University Hospital Leuven Leuven Germany From the Institut Jules Bordet and European Organization for Research and Treatment of CancerBrussels; Universitaire Ziekenhuis Gasthuisberg, Leuven, Belgium; Clatterbridge Hospital, Bebington; Western Infirmary, Glasgow, United Kingdom; Hospital General de Asturias, Oviedo; Universidad Hospital 12 de Octubre, Madrid, Spain; Libera Universita “Campus Bio-Medico,” Rome; Ospedale Civile Maggiore, Verona; Spedali Civili di Brescia, Brescia, Italy; Instituto Portugues, Lisbon, Portugal; and Debiopharm,... Christian Kurzeder and Andreas du Bois, Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Kliniken Essen Mitte, Essen; Frederik Marmé, AGO and University Hospital Heidelberg, Heidelberg; Joern Rau and Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg; Sven Mahner, AGO and University Medical Center Hamburg-Eppendorf, Hamburg; Sandra Polleis, AGO Study Group, Wiesbaden, Germany; Isabel Bover, Grupo Español de Investigación en Cáncer de Ovario ... 53Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; Ignace Vergote, University Hospitals Leuven, Leuven, Belgium; Deborah Armstrong, Johns Hopkins University, Baltimore, MD; Giovanni Scambia, Policlinico Universitario “A. Gemelli”, Rome, Italy; Michael Teneriello, US Oncology, The Woodlands, TX; Jalid Sehouli, Charité - Universitätsmedizin Berlin, Berlin, Germany; Charles Schweizer, Susan C. Weil, Wenquan Wang, and Daniel O’Shannessy, Morphotek, Exton, PA; Aristotelis Bamias, Alexandra Hospital, Athens, Greece; Keiichi Fujiwara, Saitama Medical University... 1Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.; 2Division of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. ENGOT/BGOG and University Hospital Leuven, Gynaecological Oncology Leuven Cancer Institute, Leuven, Belgium, European Union ignace.vergote@uz.kuleuven.ac.be. Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium Eric Pujade-Lauraine, Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Université Paris Descartes, Assistance Publique–Hôpitaux de Paris, Paris; Béatrice Weber, GINECO and Centre Alexis Vautrin, Vandoeuvre-les-Nancy; Philippe Follana, GINECO and Centre Antoine-Lacassagne, Nice; Isabelle Ray-Coquard, GINECO and Centre Léon Bérard, Lyon, France; Felix Hilpert, Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Klinik für Gynäkologie und Geburtshilfe, Kiel; Alexander Reuss... 8Department of Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Elisabeth Maritschnegg, Nina Pecha, Reinhard Horvat, Paul Speiser, and Robert Zeillinger, Medical University of Vienna, Vienna, Austria; Yuxuan Wang, Isaac Kinde, Luis A. Diaz Jr, Nickolas Papadopoulos, Kenneth W. Kinzler, and Bert Vogelstein, Johns Hopkins University, Baltimore, MD; Els Van Nieuwenhuysen and Ignace Vergote, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; Florian Heitz, Kliniken Essen Mitte, Essen; and Jalid Sehouli, Charité Medical University, Berlin, Germany. Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University Hospitals, Leuven, Belgium. Ignace.Vergote@uz.kuleuven.ac.be Department of Oncology, KU Leuven–University of Leuven, Leuven, Belgium.; Department of Obstetrics and Gynaecology, Gynaecologic Oncology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. From the Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; National Center for Scientific Research “Demokritos,” IPC, Athens, Greece; Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, University of Turin, Turin, Italy; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Leuven, Belgium; Department of Obstetrics and Gynecology, University... Author affiliations appear at the end of this article. 6Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium. Department of Obstetrics and Gynaecology, University Hospitals Leuven, Belgium Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. 90Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Authors' Affiliations: 1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; 2Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA; 3Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; 4Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA; 5Department of Oncology, University of Cambridge, Cambridge, UK; 6Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; 7Cancer Division, Queensland Institute of Medical Research, Herston, QLD, Australia; 8Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 9Department of Epidemiology, University of Washington, Seattle, WA, USA; 10Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; 11Department of Epidemiology, Harvard School of Public Department of Gynecologic Oncology and Leuven Cancer Institute, Catholic University of Leuven, Leuven, Belgium University Hospitals Leuven, Leuven, Belgium. Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, KU Leuven—University of Leuven, and University Hospitals Leuven, Leuven Lymphedema Center, Leuven, Belgium. Department of Gynaecology, University Hospitals Leuven, Belgium University Hospital Leuven, Leuven Cancer Institute, Leuven and BGOG, Belgium University of Leuven Leuven Belgium Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology University Hospitals Leuven, Leuven Cancer Institute Leuven Belgium Division of Gynecological Oncology Department of Obstetrics and Gynecology and Leuven Cancer Institute University Hospitals Leuven Katholieke Universiteit Leuven Leuven Belgium Gynecologic Oncologic Department, University Hospital Leuven, Department of Gynecologic oncology, Leuven Cancer Institute, Leuven, BGOG, Belgium Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Belgium; Department of Oncology, Leuven Cancer Institute, Laboratory of Gynaecologic Oncology, KU Leuven, Belgium; Department of Gynaecology and Obstetrics, Leuven Cancer Institute, UZ Leuven, Leuven, Belgium The European Organisation for Research and Treatment of Cancer, Brussels, Belgium Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium. Eric Pujade-Lauraine, Centre des Cancers de la Femme et Recherche Clinique, Paris; Frédéric Selle, Hôpitaux Universitaires de l’Est Parisien-site Tenon and Alliance Pour la Recherche En Cancérologie, Paris; Béatrice Weber, Centre Alexis Vautrin, Vandoeuvre-les-Nancy; Isabelle-Laure Ray-Coquard, Centre Léon Bérard and Université Claude Bernard-Lyon I, Lyon; Alain Lortholary, Centre Catherine de Sienne, Nantes; Anne Lesoin, Centre Oscar Lambret, Lille; Philippe Follana, Centre Antoine-Lacassagne, Nice;... Obstetrics and Gynecology Department and Leuven Cancer Institute KU/University Hospital Leuven Leuven Belgium University Hospitals Leuven, Leuven, Belgium From the University Paris Descartes, Assistance Publique-Hôpitaux de Paris, Hôpital Hôtel-Dieu; Association de Recherche sur les Cancers dont Gynécologiques Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris; Centre Catherine De Sienne, Nantes; Centre Hospitalier Universitaire-Centre François Baclesse, Caen, France; Philipps University Marburg, Marburg; University Hospital Charité/Campus Virchow-Klinikum, Berlin; Klinikum Offenbach, Offenbach; Dr Horst Schmidt Klinik, Wiesbaden,... Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute University Hospitals Leuven Leuven Belgium Department of Obstetrics and Gynecology University Hospital Leuven Leuven Cancer Institute Leuven Belgium Gynaecological Oncology, Leuven Cancer Institute, Leuven 3000, Belgium Department of Gynaecological Oncology, UZ-Katholieke Universiteit Leuven, Leuven, Belgium Authors' Affiliations: 1Department of Health Sciences Research, Division of Epidemiology; 2Department of Medical Oncology; 3Department of Health Sciences Research, Division of Biomedical Statistics and Informatics; 4Department of Laboratory Medicine and Pathology, Division of Experimental Pathology; 5Department of Immunology; 6Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota; 7Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; 8Department of Epidemiology and Biostatistics; 9Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York; 10Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas; 11Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center; 12Women's Cancer Program, 13Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; 14Department of Medicine, Division of Hematology and Onco 9Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Division of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium Andreas du Bois, Rainer Kimmig, Klaus H. Baumann, Christian Kurzeder, Ulrich Canzler, Philipp Harter, AGO Ovarian Cancer Study Group (AGO); Andreas du Bois, Christian Kurzeder, Philipp Harter, Kliniken Essen Mitte; Rainer Kimmig, West German Tumor Center, University of Duisburg-Essen, Essen; Joern Rau, Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg; Klaus H. Baumann, University of Marburg, Marburg; Ulrich Canzler, University Hospitals Carl Gustav Carus,... Center for Human Genetics, KU Leuven–University of Leuven, University Hospitals Leuven, Belgium From the Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen (P. Harter, A. du Bois), Department of Gynecology, Charité–Universitätsmedizin Berlin, Berlin (J.S.), the Coordinating Center for Clinical Trials, Philipps University Marburg (A.R., C.S.-B.), and the Department of Gynecology and Obstetrics, University Hospital Giessen and Marburg (U.W.), Marburg, the Department of Gynecology and Obstetrics, Kaiserswerther Diakonie (B.L.), and the Department of Obstetrics and... Multidisciplinary Breast Center and Gynecological Oncology, Leuvens Kanker Instituut, Leuven, Belgium Authors' Affiliations: 1Departments of Epidemiology & Population Health, Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York; 2Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 3Gynecologic Oncology, Department of Women's Oncology, Moffitt Cancer & Research Center, Tampa, Florida; 4University of Cambridge, Cambridge, England, United Kingdom; 5Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia; 6on behalf of the Australian National Endometrial Cancer Study, Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia, 7Cells and Tissues Domain, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; 8Vesalius Research Center, VIB and K.U. Leuven, Campus Gasthuisberg, Leuven, Belgium; 9Department of Gynaecologic Oncology, UZ From the Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium ENGOT Office, 1-3 rue de Chantepoulet, PO Box 1726, 1211 Geneva, Switzerland. engot@esgo.org From the Katholieke Universiteit Leuven; Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven; Virga Jesse Hospital, Hasselt, Belgium; Auckland Breast Cancer Registry, Greenlane Clinical Centre; Regional Cancer Centre, Auckland City Hospital, Auckland, New Zealand; Ullevål University; and Norwegian Radium Hospital, Oslo, Norway. Division of Gynecologic Oncology, University Hospital Leuven Leuven Cancer Institute, KU Leuven Leuven Belgium AGO and Leuven Cancer Institute, University Hospital Leuven, Leuven, Belgium. Division of Gynecologic Oncology Leuven Cancer Institute, University Hospitals Leuven, KU Leuven Leuven Belgium Joyce F. Liu, Dana-Farber Cancer Institute, Boston; Isabelle Tabah-Fisch and Joseph Pearlberg, Sanofi Oncology; Victor Moyo, Kaveh Riahi, Rachel Nering, William Kubasek, Bambang Adiwijaya, Akos Czibere, and Gavin MacBeath, Merrimack Pharmaceuticals, Cambridge, MA; R. Wendel Naumann, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, Houston, TX; Isabelle Ray-Coquard, Centre Léon Bérard, University Claude Bernard, and Groupe d’Investigateurs... Division of Gynecologic Oncology Department of Obstetrics and Gynaecology and Leuven Cancer Institute University Hospitals Leuven Leuven Belgium Department of Oncology; Leuven Cancer Institute; KU Leuven; Leuven, Belgium; Department of Gynecology and Obstetrics; UZ Leuven; Leuven, Belgium Department of Obstetrics and Gynecology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Belgium Department of Obstetrics and Gynaecology , Leuven , Belgium; University Hospitals Leuven , Leuven , Belgium Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium, European Union BGOG and University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium 64Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium. Division of Gynecologic Oncology, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium 1Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.; 2Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium. Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Belgium From the Department of Obstetrics & Gynecology, University Hospital Gasthuisberg, Katholieke Universiteit, Leuven; National Alliance of Christian Sickness Funds; Belgian Cancer Registry, Brussels; Obstetrics and Gynecology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium; Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Obstetrics and Gynecology, Charles University, Prague, Czech Republic. |
Incoming Links
Total number of triples: 612.